|
||
| |||||||
|
|
ST. LOUIS, MO, and Taufkirchen, Germany, 14th October 2005 - Sigma-Aldrich (Nasdaq: SIAL), a leading $1.4 billion Life Science and High Technology company, is pleased to announce the availability of the MyriaScreen Diversity Collection of drug-like screening compounds. The collection, produced in collaboration with TimTec Inc., is the result of careful evaluation, filtering, and refinement of selections from each of our screening compound collections. The MyriaScreen Diversity Collection is comprised of 10,000 high-purity screening compounds handpicked to maximize chemical diversity while maintaining drug-likeness. The MyriaScreen Diversity Collection was assembled from a pool of over 300,000 screening compounds using a combination of filters, diversity predictors, and manual selection. The resulting 10,000 compounds are drug-like, chemically diverse, and amenable to follow-up chemistry and optimization. The collection is well suited for researchers that are looking for a small, cost-effective, ready-to-screen set of high-quality screening compounds. "MyriaScreen will complement our customers' existing screening collections and jump-start new collections by quickly adding interesting chemotypes," said Michael Earley, Product Manager, Drug Discovery, Sigma-Aldrich. "Our collaboration with TimTec, Inc. resulted in a high-quality library that our customers will find useful." About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. The Company's biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. It has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 35 countries and has over 6,800 employees providing excellent service worldwide. The Company is committed to Accelerating the success of its Customers through leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning Web site at http://sigma-aldrich.com . Media enquiries in Europe to Northbank Communications: Marc Egelhofer, Tel: +44 (0)1260 296505 m.egelhofer@northbankcommunications.com At Sigma-Aldrich: Mike Earley, Tel: +1-508-651-8151 Joan Suda, Tel: +1-314-286-7626 |
|
| ||||||||
